Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pulmonary Hypertension Associated With Trastuzumab-Emtansine: An Analysis of French PH Registry and WHO Pharmacovigilance Database.
Poisson C, Hlavaty A, Favrolt N, Chaumais MC, Grynblat J, Jutant EM, Lechartier B, Maurac A, Mouillot P, Palat S, Rambach L, Antigny F, Cottin V, Beltramo G, Humbert M, Khouri C, Bonniaud P, Montani D. Poisson C, et al. Among authors: hlavaty a. Chest. 2024 Nov 19:S0012-3692(24)05562-4. doi: 10.1016/j.chest.2024.11.006. Online ahead of print. Chest. 2024. PMID: 39571726 Free article.
Investigating the association between ALK receptor tyrosine kinase inhibitors and pulmonary arterial hypertension: a disproportionality analysis from the WHO pharmacovigilance database.
Khouri C, Hlavaty A, Roustit M, Cracowski JL, Chaumais MC, Humbert M, Montani D. Khouri C, et al. Among authors: hlavaty a. Eur Respir J. 2021 Dec 2;58(6):2101576. doi: 10.1183/13993003.01576-2021. Print 2021 Dec. Eur Respir J. 2021. PMID: 34588195 Free article. No abstract available.
Characteristics and outcomes of patients developing pulmonary hypertension associated with proteasome inhibitors.
Grynblat J, Khouri C, Hlavaty A, Jaïs X, Savale L, Chaumais MC, Kularatne M, Jevnikar M, Boucly A, Antigny F, Perros F, Simonneau G, Sitbon O, Humbert M, Montani D; and the French PH Network PULMOTENSION Investigators. Grynblat J, et al. Among authors: hlavaty a. Eur Respir J. 2024 Jun 28;63(6):2302158. doi: 10.1183/13993003.02158-2023. Print 2024 Jun. Eur Respir J. 2024. PMID: 38697649
Development and validation of a code-based algorithm using in-hospital medical records to identify patients with pulmonary arterial hypertension in a French healthcare database.
Jambon-Barbara C, Hlavaty A, Bernardeau C, Bouvaist H, Chaumais MC, Humbert M, Montani D, Cracowski JL, Khouri C. Jambon-Barbara C, et al. Among authors: hlavaty a. ERJ Open Res. 2024 Aug 12;10(4):00109-2024. doi: 10.1183/23120541.00109-2024. eCollection 2024 Jul. ERJ Open Res. 2024. PMID: 39135662 Free PMC article.
Genesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID-19 pandemic.
Larrouquere L, Gabin M, Poingt E, Mouffak A, Hlavaty A, Lepelley M, Khouri C, Bellier A, Alexandre J, Bedouch P, Bertoletti L, Bordet R, Bouhanick B, Jonville-Bera AP, Laporte S, Le Jeunne C, Letinier L, Micallef J, Naudet F, Roustit M, Molimard M, Richard V, Cracowski JL. Larrouquere L, et al. Among authors: hlavaty a. Fundam Clin Pharmacol. 2020 Jun;34(3):389-396. doi: 10.1111/fcp.12564. Fundam Clin Pharmacol. 2020. PMID: 32394481 Free PMC article.
50 results